BioSpecifics Technologies Corp (BSTC) Financial Statements (2025 and earlier)

Company Profile

Business Address 35 WILBUR ST
LYNBROOK, NY 11563
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments99,052104,21989,23981,85985,27784,497
Cash and cash equivalent16,87219,1344,99912,76913,97317,597
Short-term investments82,18185,08584,24069,09071,30466,900
Receivables11,69717,75119,06617,76916,73016,477
Prepaid expense    952  
Other undisclosed current assets1,3108999668371,012604
Total current assets:112,059122,868109,271101,416103,019101,578
Noncurrent Assets
Operating lease, right-of-use asset201221239   
Property, plant and equipment6568    
Long-term investments and receivables20,7919,38616,56916,4938,2333,635
Long-term investments20,7919,38616,56916,4938,2333,635
Intangible assets, net (including goodwill)532564573563494426
Intangible assets, net (excluding goodwill)532564573563494426
Other noncurrent assets133139    
Other undisclosed noncurrent assets     154314
Total noncurrent assets:21,72210,37817,38217,0558,8814,375
TOTAL ASSETS:133,782133,247126,653118,471111,900105,953
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,0901,6299988777111,945
Taxes payable   355   
Employee-related liabilities6381820994106428
Accounts payable346216 878560
Accrued liabilities9843583645233501,078
Other undisclosed accounts payable and accrued liabilities1221,03570173170379
Debt 797769   
Other undisclosed current liabilities1,6731,640355 8791,803
Total current liabilities:3,8423,3461,4228771,5893,748
Noncurrent Liabilities
Long-term debt and lease obligation:127147167   
Liabilities, other than long-term debt396484573593  
Deferred income tax liabilities396484573593  
Operating lease, liability127147167   
Total noncurrent liabilities:523631740593  
Total liabilities:4,3643,9782,1621,4701,5893,748
Equity
Equity, attributable to parent129,417129,269124,491117,001110,310102,205
Common stock888888
Treasury stock, value(11,932)(11,740)(11,519)(11,256)(11,017)(10,898)
Additional paid in capital40,08039,85639,35638,95638,30036,503
Retained earnings101,261101,14596,64789,29383,02076,593
Total equity:129,417129,269124,491117,001110,310102,205
TOTAL LIABILITIES AND EQUITY:133,782133,247126,653118,471111,900105,953

Income Statement (P&L) ($ in thousands)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Revenues3,9039,66911,7639,4428,8538,129
Cost of revenue      
Gross profit:3,9039,66911,7639,4428,8538,129
Operating expenses(4,154)(4,436)(2,808)(2,121)(1,889)(3,057)
Operating income (loss):(251)5,2338,9557,3216,9645,072
Nonoperating income391480515505517449
Investment income, nonoperating391480 505517449
Income from continuing operations before income taxes:1405,7129,4707,8267,4815,522
Income tax expense(24)(1,214)(2,116)(1,553)(1,054)(1,105)
Income from continuing operations:1164,4997,3546,2736,4264,417
Income before gain (loss) on sale of properties:1164,4997,3546,2736,4264,417
Net income available to common stockholders, diluted:1164,4997,3546,2736,4264,417

Comprehensive Income ($ in thousands)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Net income:1164,4997,3546,2736,4264,417
Comprehensive income, net of tax, attributable to parent:1164,4997,3546,2736,4264,417

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: